Dr. Eric D. Morse, MD

Dr. Morse practices at Mercy Medical Group, A Service Of Dignity Health Medical Foundation in Carmichael, California.

Dr. Morse's NPI, 1730290131, was assigned on August 31, 2006. Dr. Morse graduated from David Geffen School of Medicine at UCLA in 1985. Dr. Morse holds California license G57714.

Dr. Morse's primary practice is Mercy Medical Group, A Service of Dignity Health Medical Foundation, at 6555 Coyle Ave Suite 280 Suite 280, Carmichael, CA 95608-0302. The practice phone is (916) 536-3540.

Dr. Morse's primary practice is Mercy Medical Group, A Service Of Dignity Health Medical Foundation in Carmichael, California. Dr. Morse is also affiliated with Dignity Health - Mercy San Juan Medical Center. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Morse to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morse practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Morse's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Morse is board certified in surgery by the American Board of Surgery. Dr. Morse is licensed in California.

Dmand AI lists abdominal hernia repair surgery, gallbladder removal, gastrointestinal bleeding, groin hernia surgery and mastectomy among the conditions Dr. Morse treats.

CMS data shows 178 Medicare services from Dr. Morse across 3 procedure codes in 2024, all of them office visits, for 190 Medicare patients. Medicare paid $13,079 for them. Every service was in an office.

CMS counts 190 Medicare patients who saw Dr. Morse in 2026. The largest group is 65 to 74, with 90 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morse's median patient age at 59, with 47% women.

In 2026, Dr. Morse wrote 31 Medicare Part D claims for 30 patients. 100% of them were for generic drugs. CMS names the drug for 30 of them, across 1 drug with 11 or more claims each, at $397 in total drug cost. In 2023, CMS named 44 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Morse for performance year 2026, reported through an alternative payment model (APM). Dr. Morse accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of hernia repair - groin (open) by Dr. Morse, more than 92% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Morse. Dr. Morse's most frequent co-author is Ira Glick.

CMS Open Payments shows 10 general payments to Dr. Morse from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Pacira Pharmaceuticals Incorporated paid the most, $219.

Dr. Morse graduated from David Geffen School of Medicine at UCLA in 1985.

Dr. Morse is in network with 12 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.